Drug Repurposing in Cancer Research
- 1st Edition - February 1, 2027
- Latest edition
- Editors: Ranjita Shegokar, Yashwant Pathak
- Language: English
Drug Repurposing in Cancer Research investigates the innovative use of drug repurposing in oncology, focusing on emerging and re-emerging cancer types. The book provides a compre… Read more
Description
Description
Key features
Key features
- Provides a thorough yet concise examination of current trends in drug repurposing and theranostics within oncology
- Offers foundational facts alongside actionable insights, supporting effective research and clinical applications
- Highlights the rapid advancements and market dynamics in cancer treatment, ensuring readers stay informed about the latest developments
Readership
Readership
Table of contents
Table of contents
2. Drug Repurposing in Pancreatic Cancer
3. Drug Repurposing in Heart/Cardiac Cancer
4. Drug Repurposing in Bone Cancer
5. Drug Repurposing in Spleen Cancer
6. Drug Repurposing in ENT Cancer
7. Drug Repurposing in Brain/CNS Cancer
8. Drug Repurposing in Skin Cancer
9. Drug Repurposing in Lung Cancer
10. Drug Repurposing in Thorax Cancer
11. Drug Repurposing in Thyroid Cancer
12. Drug Repurposing in Kidney-Adrenal Cancer
13. Drug Repurposing in Urinary Tract Cancer
14. Drug Repurposing in Breast Cancer
15. Drug Repurposing in Colorectal Cancer
16. Drug Repurposing in Blood Cancer
17. Drug Repurposing in Prostate Cancer
18. Drug Repurposing in Ovarian Cancer
19. Drug Repurposing in Stomach and Intestinal Cancer
20. Drug Repurposing in Pleura and Peritoneum Cancer
21. Drug Repurposing in Oral Cancer
Product details
Product details
- Edition: 1
- Latest edition
- Published: February 1, 2027
- Language: English
About the editors
About the editors
RS
Ranjita Shegokar
Ranjita Shegokar holds a Ph.D. degree in Pharmaceutical Technology from the SNDT University, India, and has been a postdoctoral researcher in the Department of Pharmaceutics, Biopharmaceutics and NutriCosmetics at the Free University of Berlin, Germany. Currently, she serves as Chief Scientific Officer (CSO) at Capnopharm GmbH, Germany. She has authored several research articles, book chapters, and presented her research in many national/international conferences. She has filed multiple patent applications in the area of drug delivery and targeting. Besides that, she has edited many trending books in the area of pharmaceutical nanotechnology and drug delivery aspects. For her research, she has received many prestigious national and international awards among them include recently received prestigious German Innovation Award 2022. Her areas of interest include polymeric nanoparticles, nanocrystals, lipid nanoparticles (SLNs/NLCs), nanoemulsions, cancer drug targeting and the role of excipients in delivery systems. (www.ranjitas.com)
YP